Multicell Technologies (MCET) Return on Assets ROA from the second quarter of 2015 to second quarter of 2014 and for the year 2015, Average High and Low, Fundamental Ratios from May 31 2015 to May 31 2014 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Multicell Technologies, Inc.  (MCET)


Multicell Technologies's ROA from the second quarter of 2015 to the second quarter of 2014 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Multicell Technologies's ROA in the second quarter of 2015?
Due to the lack of assets, it was not possible to calculate Multicell Technologies, Inc.'s return on assets (ROA) in its second quarter of 2015

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (May 31 2015)
II. Quarter		 (Feb 28 2015)
I. Quarter		 (Nov 30 2014)
IV. Quarter		 (Aug 31 2014)
III. Quarter		 (May 31 2014)
II. Quarter
Y / Y Total Assets Change 130.51 % -75.19 % -29.5 % -55.57 % -18.87 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 0 0 -1 -1 -1
Return On Assets (TTM) 62.73 % -379 % -294.11 % -456.19 % -599.26 %
MCET's Total Ranking # 123 # 5496 # 5583 # 5325 # 5339
Total Assets (TTM) in million 0 0 0 0 0
Seq. Total Assets Change 536.27 % -47.63 % -12.24 % -21.16 % -31.53 %
Seq. Net Income Change - - - - -

MCET's 5 Years Annual ROA >> Back to MCET Management Effectiveness >> Compare MCET ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 3
Sector # 15
Overall # 87

Return On Assets Statistics
High Average Low
62.73 %
-418.88 %
-599.29 %
(May 31 2015)   (May 31 2014)





Financial Statements
Multicell Technologies's Assets $ 0 million MCET's Balance sheet
Multicell Technologies's Income $ 0 million Quarterly MCET's Income Statement
MCET's Income by Division See MCET's Income by Division



Annual Return On Assets (Nov 30 2014)
FY 2014		 (Nov 30 2013)
FY 2013		 (Nov 30 2012)
FY 2012		 (Nov 30 2011)
FY 2011
FY
Y / Y Total Assets Change -29.5 % -15.13 % -70.72 % - -
Total Assets in million 0 0 0 1 0
Y / Y Net Income Change - - - - -
Net Income in million -1 -1 -1 -2 0
Annual Return On Assets -418.82 % -764.66 % -643.86 % -270.84 % -

MCET's 5 Years Annual ROA >> Back to MCET Management Effectiveness >> Compare MCET ROA to its Competitors



More Return On Assets Ratios
MCET's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MCET's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MCET's Competitors
Subscribers only: Roa for Multicell Technologies's Suppliers
Subscribers only: Return On Assets for MCET's Customers

You may also want to know
MCET's Roi MCET's Inventory Turnover Ratio MCET's Growth Rates MCET's Dividend Comparisons
MCET's Profitability Ratios MCET's Asset Turnover Ratio MCET's Dividend Growth
MCET's Roe MCET's Valuation Ratios MCET's Financial Strength Ratios MCET's Dividend Payout Ratio



Companies with similar Return On Assets at May 31 2015, within Healthcare Sector ROA
Rafina Innovations Inc.  172.44 %
Elite Pharmaceuticals Inc   156.78 %
Streamex Corp   149.33 %
Wearable Health Solutions, Inc.  147.22 %
Fennec Pharmaceuticals Inc   103.25 %
Armata Pharmaceuticals Inc   96.96 %
Advanced Container Technologies Inc   95.91 %
Viskase Holdings inc   67.88 %
Multicell Technologies, Inc.  62.73 %
Mit Holding, Inc.  61.89 %
Adm Tronics Unlimited Inc   59.37 %
Lumos Pharma Inc   57.29 %
Reflect Scientific Inc  49.42 %
Cba Florida Inc   49.09 %
Abiomed Inc   43.34 %
Gilead Sciences Inc   42.60 %
Pacific Health Care Organization Inc  36.34 %
Enanta Pharmaceuticals Inc  34.31 %
Journey Medical Corp  34.03 %
Lannett Company Inc  33.90 %
Brainstorm Cell Therapeutics inc   31.98 %
Vanda Pharmaceuticals Inc   30.62 %
Sientra Inc   29.55 %
Proteo Inc  29.23 %
Orgenesis Inc   27.88 %
Supernus Pharmaceuticals inc   25.75 %
Misonix Inc   25.14 %
China Biologic Products Holdings Inc   23.95 %
Biogen Inc   23.28 %
Biospecifics Technologies Corp  22.64 %

Date modified: 2026-09-18T13:11:02+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.